subject: PUBCHEM.COMPOUND:155977629


subject: PUBCHEM.COMPOUND:155977629

object_name: Primary malignant neoplasm

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:155977629

object_name: cancer


subject: CHEBI:89981

subject_name: Endotoxins

object_name: Malignant neoplasm of abdomen


subject: CHEBI:89981


subject: CHEBI:89981


subject: UNII:LR3UXN0193

subject_name: Methoxy polyethylene glycol-epoetin beta

object_name: Renal anaemia

tested_intervention: yes


subject: UMLS:C2342719

subject_name: calcium levofolinate

object_name: pancreatic ductal adenocarcinoma


subject: GTOPDB:12848


subject: UMLS:C5555591

subject_name: netrin-1 inhibitor NP137


subject: UMLS:C1330033

subject_name: Acular LS

object_name: OPTN-related open angle glaucoma


subject: UMLS:C1330033

object_name: open-angle glaucoma


subject: PUBCHEM.COMPOUND:4895

subject_name: Pred Forte


subject: PUBCHEM.COMPOUND:4895


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: substance-related disorder


subject: UMLS:C3714835

subject_name: Multivitamin Drug Class


subject: HMDB:HMDB0001349

subject_name: Selenium


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Erectile dysfunction due to diabetes mellitus


subject: UMLS:C5235841

subject_name: Anti-IL-6 Monoclonal Antibody

object_name: ovarian cancer


subject: UMLS:C5235841

object_name: ovarian neoplasm


subject: UMLS:C5235841

object_name: head and neck neoplasm


subject: UMLS:C5235841

object_name: pancreatic neoplasm


subject: UMLS:C5235841

object_name: colorectal neoplasm


subject: UMLS:C5235841

object_name: lung neoplasm


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: poisoning by anticholinergics


subject: PUBCHEM.COMPOUND:75038

object_name: Prediabetes


subject: PUBCHEM.COMPOUND:75038

object_name: Beta-cell dysfunction


subject: PUBCHEM.COMPOUND:75038

object_name: Insulin Sensitivity


subject: PUBCHEM.COMPOUND:75038

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:75038

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:75038

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:75038

object_name: obesity


subject: PUBCHEM.COMPOUND:75038

object_name: Obesity, CTCAE


subject: CHEBI:44245

subject_name: Menaquinone 7


subject: CHEBI:44245


subject: CHEBI:44245


subject: CHEBI:44245


subject: CHEBI:44245


subject: CHEBI:44245


subject: CHEBI:44245


subject: CHEBI:44245


subject: CHEBI:31355

subject_name: Carboplatin

object_name: anus cancer


subject: CHEBI:31355

object_name: anal carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:145831

subject_name: monoacylglycerol 16:5

object_name: Overweight


subject: CHEBI:145831


subject: CHEBI:145831


subject: CHEBI:145831


subject: CHEBI:24848

subject_name: inositol

object_name: periodontitis


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Recurrent Lung Non-Squamous Non-Small Cell Carcinoma


subject: CHEBI:231679

object_name: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma


subject: UMLS:C2830131

object_name: Solid Neoplasm


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Malignant neoplasm of anorectum


subject: CHEBI:85994

object_name: squamous cell carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:82715

object_name: chronic obstructive pulmonary disease


subject: UMLS:C5238987

object_name: Metastatic Malignant Solid Neoplasm


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: PUBCHEM.COMPOUND:21014972

subject_name: Telavancin

object_name: Staphylococcal Skin Infections


subject: CHEBI:15367

subject_name: Tretinoin

object_name: cervical cancer


subject: CHEBI:15367

object_name: cervical carcinoma


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:50648


subject: UNII:28P3DU6DB3

subject_name: Giredestrant

object_name: BREAST CANCER, EARLY-ONSET


subject: CHEBI:3219

subject_name: Bupropion

object_name: amphetamine abuse


subject: CHEBI:71956

subject_name: retaspimycin hydrochloride

object_name: sarcoma


subject: CHEBI:71956

object_name: soft tissue sarcoma


subject: CHEBI:71956

object_name: Plexosarcoma


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: UMLS:C1708447

subject_name: IPI 504


subject: UMLS:C1708447


subject: UMLS:C1708447


subject: UNII:09J8QNB0L9

subject_name: CRYOPRECIPITATE

object_name: congenital heart disease


subject: UMLS:C0443121

subject_name: Cryoprecipitate (product)


subject: UMLS:C5553020

subject_name: Cryoprecipitated Plasma


subject: CHEBI:3752

subject_name: Clomifene

object_name: Allergy to clomiphene


subject: CHEBI:3752

object_name: vitamin D deficiency


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:194425

subject_name: Lobaplatin

object_name: Childhood Breast Carcinoma


subject: CHEBI:194425

object_name: breast carcinoma


subject: CHEBI:194425

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEBI:192744

subject_name: lobaplatin


subject: CHEBI:192744


subject: CHEBI:192744


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: salivary gland cancer


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: High Grade Sarcoma


subject: CHEBI:39867

subject_name: Valproic acid


subject: UMLS:C2984027

object_name: non-Hodgkin lymphoma


subject: UMLS:C2984027

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: Well adult


subject: PR:000023560

subject_name: nicotinamidase


subject: CHEBI:16171

subject_name: NMN zwitterion


subject: PUBCHEM.COMPOUND:6093202

subject_name: Nicotinamide Mononucleotide


subject: CHEBI:14648

subject_name: NMN(+)


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease

object_name: rheumatoid arthritis


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: UMLS:C0358845

subject_name: Analgesics and non-steroidal anti-inflammatory drugs


subject: CHEBI:9150

subject_name: Simvastatin

object_name: chronic kidney disease


subject: UMLS:C3827036

subject_name: Zirconium Zr 89-labeled Monoclonal Antibody MMOT0530A

object_name: pancreas disorder


subject: UMLS:C3827036

object_name: pancreatic neoplasm


subject: UMLS:C3827036

object_name: ovarian disease


subject: UMLS:C3827036

object_name: ovarian cancer


subject: UMLS:C3827036

object_name: ovarian neoplasm


subject: UMLS:C3827036

object_name: digestive system neoplasm


subject: UMLS:C3827036

object_name: digestive system disorder


subject: UMLS:C3827036

object_name: Adnexal Diseases


subject: UNII:5YSY733NA3

object_name: Relapsing acute myeloid leukemia


subject: UNII:5YSY733NA3

object_name: recurrent adult acute myeloid leukemia


subject: UMLS:C2987373


subject: UMLS:C2987373


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine

object_name: metastatic squamous cell carcinoma


subject: UNII:39IS23Q1EW

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UNII:39IS23Q1EW

object_name: head and neck squamous cell carcinoma


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: DRUGBANK:DB19248

subject_name: Bifidobacterium longum

object_name: Infrequent bowel movements


subject: DRUGBANK:DB19248

object_name: Chronic constipation


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: congenital heart disease


subject: CHEBI:5931

subject_name: insulin human


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine

object_name: lichen planus, oral


subject: MESH:C530960

subject_name: yunnan baiyao

object_name: Distal Radius Fractures


subject: CHEMBL.COMPOUND:CHEMBL1200571

subject_name: GADOBENATE DIMEGLUMINE

object_name: CNS disorder


subject: UNII:3Q6PPC19PO


subject: GTOPDB:4985

object_name: Infection


subject: GTOPDB:4985

object_name: infectious disease


subject: GTOPDB:4985

object_name: Adverse Event Associated with Infection


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: CHEBI:91418

subject_name: Foretinib

object_name: liver carcinoma


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: heart failure


subject: CHEBI:85083

object_name: Heart Failure, CTCAE


subject: CHEBI:85083

object_name: interstitial lung disease


subject: CHEBI:85083

object_name: COPD, severe early onset


subject: CHEBI:85083

object_name: chronic obstructive pulmonary disease


subject: PR:000022493


subject: PR:000022493


subject: PR:000022493


subject: PR:000022493


subject: PR:000022493


subject: CHEBI:44241

subject_name: Metyrapone

object_name: Cushing syndrome


subject: CHEBI:44241

object_name: hyperaldosteronism


subject: CHEBI:29033

subject_name: Ferrous cation


subject: CHEBI:29033


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Plasma cell myeloma recurrent


subject: PR:000001379


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: HLA-A*0201 Positive Cells Present


subject: CHEBI:63791

object_name: NY-ESO-1 Positive Tumor Cells Present


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:35812

subject_name: Oxfendazole

object_name: helminthiasis


subject: UNII:6T4O391P5Y

subject_name: Vactosertib

object_name: pancreatic neoplasm


subject: UNII:6T4O391P5Y

object_name: exocrine pancreatic carcinoma


subject: UNII:6T4O391P5Y

object_name: malignant pancreatic neoplasm


subject: CHEBI:32599

object_name: Cough


subject: CHEBI:32599

object_name: Cough, CTCAE


subject: CHEBI:15365

subject_name: Aspirin

object_name: sudden sensorineural hearing loss


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:23965

subject_name: estradiol

object_name: Abnormal vaginal bleeding


subject: CHEBI:23965

object_name: Vaginal Hemorrhage


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: CHEBI:132082

subject_name: Entinostat

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:132082

object_name: HER2 positive


subject: CHEBI:49603

subject_name: Lapatinib

object_name: invasive breast carcinoma


subject: CHEBI:231601

subject_name: trastuzumab


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: priapism


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UNII:8BR2SOL3L1

object_name: urothelial carcinoma


subject: UNII:8BR2SOL3L1

object_name: transitional cell carcinoma


subject: DRUGBANK:DB12813

subject_name: Radium Ra-223


subject: DRUGBANK:DB12813


subject: CHEBI:367163

subject_name: Darunavir

object_name: hepatitis C


subject: CHEBI:48923

subject_name: erythromycin


subject: CHEBI:42355

subject_name: Erythromycin


subject: UMLS:C5855614

subject_name: Copper Cu 64 GRIP B

object_name: renal carcinoma


subject: UMLS:C5855614

object_name: kidney cancer


subject: UMLS:C5855614

object_name: carcinoma of urethra


subject: UMLS:C5855614

object_name: urethra cancer


subject: UMLS:C5855614

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5855614

object_name: Adult Solid Neoplasm


subject: UMLS:C5855614

object_name: prostate carcinoma


subject: UMLS:C5855614

object_name: prostate cancer


subject: UMLS:C5855614

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C0796445

subject_name: Cisplatin Liposomal

object_name: ovarian cancer


subject: UMLS:C0796445

object_name: ovarian neoplasm


subject: UMLS:C0796445

object_name: ovarian carcinoma


subject: CHEBI:91432

subject_name: Brivanib

object_name: Solid Neoplasm


subject: CHEBI:31898

subject_name: Nedaplatin

object_name: cervical cancer


subject: CHEBI:31898

object_name: cervical carcinoma


subject: CHEBI:31898

object_name: complication


subject: CHEMBL.COMPOUND:CHEMBL3137685

subject_name: NEDAPLATIN


subject: CHEMBL.COMPOUND:CHEMBL3137685


subject: CHEMBL.COMPOUND:CHEMBL3137685


subject: CHEBI:83314

subject_name: vorapaxar sulfate

object_name: coronary artery disorder


subject: CHEBI:83314

object_name: peripheral vascular disease


subject: UMLS:C2974522


subject: UMLS:C2974522


subject: PUBCHEM.COMPOUND:56843330

subject_name: upamostat

object_name: Carcinoma breast stage IV


subject: UMLS:C2348191


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine

object_name: metastatic colorectal cancer


subject: CHEBI:60481

object_name: herpes simplex


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: PR:000008953

subject_name: insulin-like growth factor-binding protein 7


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:22976653

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:22976653

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:22976653

object_name: Depression, CTCAE


subject: PUBCHEM.COMPOUND:22976653

object_name: anxiety disorder


subject: UMLS:C0678113

subject_name: Actilyse


subject: UMLS:C0678113


subject: UMLS:C0678113


subject: UMLS:C0678113


subject: UMLS:C0678113


subject: UMLS:C4329341

subject_name: Renvistobart

object_name: non-small cell lung carcinoma


subject: UNII:55F75LJQ0V

subject_name: ANAMORELIN HYDROCHLORIDE

object_name: Anorexia


subject: UNII:55F75LJQ0V

object_name: Anorexia, CTCAE


subject: UNII:55F75LJQ0V

object_name: Anorexia symptom


subject: UNII:55F75LJQ0V

object_name: Stage III Lung Cancer AJCC v8


subject: UNII:55F75LJQ0V

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:55F75LJQ0V

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UNII:55F75LJQ0V

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UNII:55F75LJQ0V

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UNII:55F75LJQ0V

object_name: Stage IVA Lung Cancer AJCC v8


subject: UNII:55F75LJQ0V

object_name: Stage IVB Lung Cancer AJCC v8


subject: UMLS:C2346777

subject_name: RC-1291 HCl


subject: UMLS:C2346777


subject: UMLS:C2346777


subject: UMLS:C2346777


subject: UMLS:C2346777


subject: UMLS:C2346777


subject: UMLS:C2346777


subject: UMLS:C2346777


subject: UMLS:C2346777


subject: UMLS:C2346777


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Femur fracture


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: Recurrence in Pelvic Nodes


subject: CHEBI:6427

subject_name: Leuprolide


subject: UMLS:C1619396

subject_name: DEXAMETHASONE, ORAL, 0.25 MG ADMINISTERED

object_name: Childhood Breast Carcinoma


subject: UMLS:C1619396

object_name: breast carcinoma


subject: UMLS:C1619396

object_name: breast cancer


subject: UMLS:C3827004

subject_name: Fluorine F 18 FDHT


subject: UMLS:C3827004


subject: UMLS:C3827004


subject: UMLS:C3827004

object_name: Malignant neoplasm of female breast


subject: UMLS:C3827004

object_name: female breast carcinoma


subject: UMLS:C3827004

object_name: Carcinoma breast stage IV


subject: UMLS:C3827004

object_name: Metastatic Breast Carcinoma


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: cubital tunnel syndrome


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: autoimmune hemolytic anemia


subject: CHEBI:91397

object_name: Monoclonal B-cell lymphocytosis chronic lymphocytic leukemia-type


subject: UMLS:C0121283

subject_name: Helixor M

object_name: Childhood Solid Neoplasm


subject: UMLS:C0121283

object_name: Adult Solid Neoplasm


subject: UMLS:C0121283

object_name: Solid Neoplasm


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: head and neck squamous cell carcinoma


subject: GTOPDB:13790

subject_name: benmelstobart


subject: UNII:B25CF42QKP

subject_name: BENMELSTOBART


subject: UMLS:C5777125


subject: UMLS:C4744993


subject: CHEBI:27082

subject_name: trehalose

object_name: type 2 diabetes mellitus


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Hypothermia due to exposure


subject: CHEBI:68579

object_name: Hypothermia


subject: CHEBI:68579

object_name: Hypothermia, CTCAE


subject: CHEBI:68579

object_name: Physical trauma


subject: CHEBI:68579

object_name: Injury


subject: CHEBI:68579

object_name: Trauma


subject: CHEBI:68579

object_name: metabolic acidosis


subject: CHEBI:68579

object_name: acidosis


subject: CHEBI:68579

object_name: Acidosis, CTCAE


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: UNII:PQX0D8J21J

object_name: Cervical carcinoma stage IVA


subject: UNII:PQX0D8J21J

object_name: stage III cervical cancer


subject: UNII:PQX0D8J21J

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: UNII:PQX0D8J21J

object_name: Stage III Cervical Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IB Cervical Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: stage IB cervical cancer


subject: UNII:PQX0D8J21J

object_name: Stage IB Cervical Cancer AJCC v6 and v7


subject: UNII:PQX0D8J21J

object_name: Cervical carcinoma stage IIA


subject: UNII:PQX0D8J21J

object_name: Stage IIA Cervical Cancer AJCC v6


subject: UNII:PQX0D8J21J

object_name: Stage IIA Cervical Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IIA Cervical Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IIB Cervical Cancer AJCC v6 and v7


subject: UNII:PQX0D8J21J

object_name: Cervical carcinoma stage IIB


subject: UNII:PQX0D8J21J

object_name: Stage IIB Cervical Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: cervical adenocarcinoma


subject: UNII:PQX0D8J21J

object_name: cervical small cell carcinoma


subject: UNII:PQX0D8J21J

object_name: cervical adenosquamous carcinoma


subject: UMLS:C0879636

subject_name: IMC C225

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: UMLS:C0879636

object_name: Cervical carcinoma stage IVA


subject: UMLS:C0879636

object_name: stage III cervical cancer


subject: UMLS:C0879636

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: UMLS:C0879636

object_name: Stage III Cervical Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IB Cervical Cancer AJCC v8


subject: UMLS:C0879636

object_name: stage IB cervical cancer


subject: UMLS:C0879636

object_name: Stage IB Cervical Cancer AJCC v6 and v7


subject: UMLS:C0879636

object_name: Cervical carcinoma stage IIA


subject: UMLS:C0879636

object_name: Stage IIA Cervical Cancer AJCC v6


subject: UMLS:C0879636

object_name: Stage IIA Cervical Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IIA Cervical Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage IIB Cervical Cancer AJCC v6 and v7


subject: UMLS:C0879636

object_name: Cervical carcinoma stage IIB


subject: UMLS:C0879636

object_name: Stage IIB Cervical Cancer AJCC v8


subject: UMLS:C0879636

object_name: cervical adenocarcinoma


subject: UMLS:C0879636

object_name: cervical small cell carcinoma


subject: UMLS:C0879636

object_name: cervical adenosquamous carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UMLS:C5222496

subject_name: Repository Corticotropin Injection

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C5222496

object_name: amyotrophic lateral sclerosis


subject: PR:000014823

object_name: excess; nutrient


subject: PR:000014823

object_name: inflammatory bowel disease 1


subject: PR:000014823

object_name: Crohn disease


subject: PR:000014823

object_name: remission/regression


subject: UNII:33K3DB6591

subject_name: CYTARABINE HYDROCHLORIDE

object_name: Blasts 10 Percent or More of Bone Marrow Nucleated Cells


subject: UMLS:C0282120

subject_name: Cytarabine Hydrochloride


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: penile neoplasm


subject: CHEBI:63584

object_name: penile cancer


subject: CHEBI:34945

object_name: cystic fibrosis


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: UMLS:C0127526

subject_name: Meningococcal Polysaccharide Vaccine

object_name: meningococcemia


subject: UMLS:C0127526

object_name: meningitis


subject: UMLS:C0127526

object_name: Meningitis, CTCAE


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)

object_name: Estrogen Receptor Positive


subject: CHEBI:23965

subject_name: estradiol


subject: PUBCHEM.COMPOUND:21982135

object_name: Shoulder pain


subject: CHEBI:73038

subject_name: Parecoxib


subject: CHEBI:36796

subject_name: duloxetine

object_name: Functional disorder


subject: UNII:4R4HFI6D95

subject_name: polyethylene glycol 4000

object_name: Chronic constipation


subject: CHEMBL.COMPOUND:CHEMBL2074863


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:8228

object_name: Stage IIA Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:8228

object_name: stage IIA non-small cell lung cancer


subject: CHEBI:8228

object_name: Stage IA Lung Non-Small Cell Carcinoma AJCC v7


subject: CHEBI:8228

object_name: Stage IIB Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:8228

object_name: stage IIB non-small cell lung cancer


subject: CHEBI:8228

object_name: Stage IB Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:8228

object_name: stage IB non-small cell lung cancer


subject: CHEBI:100246

subject_name: Norfloxacin

object_name: portal hypertension


subject: CHEBI:100246

object_name: Portal Hypertension, CTCAE


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: Drug Interactions


subject: CHEBI:31348

subject_name: Capecitabine

object_name: COLON RECTAL CANCER DUKE STAGE STAGEVAL


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA

object_name: tropical spastic paraparesis


subject: UNII:XRO4566Q4R

object_name: human T-lymphotropic virus 1 infectious disease


subject: UNII:XRO4566Q4R

object_name: spinal cord disorder


subject: CHEBI:9168

subject_name: Sirolimus

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:9168

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:9168

object_name: T-cell prolymphocytic leukemia


subject: CHEBI:9168

object_name: Indolent Non-Hodgkin Lymphoma


subject: CHEBI:9168

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: CHEBI:9168

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:9168

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UMLS:C0056562

subject_name: crystalloid solutions

object_name: Abnormality of acid-base homeostasis


subject: UMLS:C0056562

object_name: Fluid Overload


subject: UMLS:C0056562

object_name: Hypervolemia


subject: UMLS:C0056562

object_name: Water-Electrolyte Imbalance


subject: PUBCHEM.COMPOUND:173480

object_name: pulmonary hypertension, primary, 1


subject: PUBCHEM.COMPOUND:173480

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:173480

object_name: idiopathic pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:173480

object_name: pulmonary arterial hypertension


subject: UMLS:C3896652


subject: UMLS:C3896652


subject: UMLS:C3896652


subject: UMLS:C3896652


subject: UMLS:C5555613

subject_name: Technetium Tc-99m-MIRC208

object_name: cancer


subject: UMLS:C5555613

object_name: neoplasm


subject: CHEBI:8364

subject_name: Prazosin

object_name: Alzheimer disease type 1


subject: CHEBI:8364

object_name: Agitation


subject: CHEBI:27732

subject_name: Caffeine

object_name: meconium aspiration syndrome


subject: CHEBI:30742

subject_name: macrogol

object_name: Anastomosis


subject: CHEBI:9753

subject_name: Troglitazone

object_name: arteriosclerosis disorder


subject: CHEBI:9753

object_name: atherosclerosis


subject: CHEBI:9753

object_name: diabetes mellitus


subject: CHEBI:52717

subject_name: Bortezomib

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:52717

object_name: T-cell childhood acute lymphocytic leukemia


subject: CHEBI:52717

object_name: Stage II Adult Lymphoblastic Lymphoma


subject: CHEBI:52717

object_name: Stage III Childhood Lymphoblastic Lymphoma


subject: CHEBI:52717

object_name: Stage II Childhood Lymphoblastic Lymphoma


subject: CHEBI:52717

object_name: Stage IV Childhood Lymphoblastic Lymphoma


subject: UMLS:C5667068

subject_name: Anti-interleukin-1 Beta Monoclonal Antibody AK114

object_name: Embolism, Tumor


subject: UMLS:C5667068

object_name: Neoplasm Metastasis


subject: UMLS:C5667068

object_name: Metastasis


subject: UMLS:C5667068

object_name: Metastatic Lesion


subject: UMLS:C5667068

object_name: Primary malignant neoplasm


subject: UMLS:C5667068

object_name: cancer


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: Senile voice


subject: CHEBI:16919

subject_name: Creatine


subject: CHEBI:72296

subject_name: Apixaban

object_name: Catheter related infection


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Corneal epithelial staining pattern


subject: CHEBI:135919

subject_name: Nesiritide

object_name: kidney disorder


subject: DRUGBANK:DB17831

subject_name: Beremagene geperpavec

object_name: generalized dominant dystrophic epidermolysis bullosa


subject: DRUGBANK:DB17831

object_name: recessive dystrophic epidermolysis bullosa


subject: CHEBI:91464

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:63452

subject_name: Midostaurin


subject: CHEBI:4670

subject_name: Dobutamine

object_name: Sepsis


subject: CHEBI:4670

object_name: Sepsis, CTCAE


subject: CHEBI:4670

object_name: Hypoperfusion


subject: CHEBI:4670

object_name: Hyperlactatemia


subject: CHEBI:3213

subject_name: Bumetanide

object_name: diabetes mellitus


subject: CHEBI:31547

subject_name: Eplerenone


subject: UMLS:C5706374

subject_name: ENPP1 Inhibitor RBS2418

object_name: Advanced cancer


subject: CHEBI:2668

subject_name: Amlodipine

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C5392407

object_name: ankylosing spondylitis


subject: UNII:0RO7MZY2LS

object_name: carpal tunnel syndrome 1


subject: UNII:0RO7MZY2LS

object_name: carpal tunnel syndrome


subject: UNII:4GU1D587JV

object_name: Nonvalvular atrial fibrillation


subject: CHEBI:3745

subject_name: clindamycin

object_name: skin disease caused by bacterial infection


subject: CHEBI:63607

subject_name: Linezolid

object_name: abscess


subject: CHEBI:63607


subject: CHEBI:63607

object_name: cellulitis


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: melanoma


subject: UMLS:C3896914


subject: PUBCHEM.COMPOUND:157010100

subject_name: Potassium citrate

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:157010100

object_name: Osteopenia


subject: CHEBI:15367

subject_name: Tretinoin

object_name: Breast neoplasm female


subject: UMLS:C0599934

subject_name: Vaccines, Peptide


subject: UMLS:C0599934

object_name: end stage renal failure


subject: UMLS:C0599934

object_name: Stage 4 chronic kidney disease


subject: UMLS:C0599934

object_name: Epstein-Barr virus-associated lymphoproliferative disorder


subject: UMLS:C0599934

object_name: EBV-Related Malignant Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: UMLS:C0310604

subject_name: VITAMIN C INJECTION

object_name: Fever


subject: UMLS:C0310604

object_name: Fever symptoms (finding)


subject: UMLS:C0310604

object_name: Fever, CTCAE


subject: UMLS:C0310604

object_name: Obstetric Labor Complications


subject: UMLS:C5203426

subject_name: Tobramycin Liquid Injection

object_name: Wound Infection


subject: UMLS:C5203426

object_name: Wound Infection, CTCAE


subject: UMLS:C5203426

object_name: Fractures, Open


subject: UMLS:C5203426

object_name: Surgical Wound Infection


subject: CHEBI:28864

subject_name: Tobramycin


subject: CHEBI:28864


subject: CHEBI:28864


subject: UMLS:C5392767

subject_name: eptacog beta

object_name: Thrombasthenia


subject: CHEBI:174615

object_name: hemophagocytic syndrome


subject: CHEBI:174615

object_name: Bone marrow depression


subject: CHEBI:174615

object_name: pancytopenia


subject: CHEBI:174615

object_name: Bone marrow hypocellularity


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:681569

subject_name: Clofarabine


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:681569

object_name: inherited hemoglobinopathy


subject: CHEBI:681569

object_name: hemoglobinopathy


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:139554

subject_name: magnetic nanoparticle

object_name: Developmental delay


subject: CHEBI:139554

object_name: Cognitive delay


subject: CHEBI:77383

subject_name: 1,1-bis(phosphonic acid)

object_name: chronic kidney disease


subject: CHEBI:77383

object_name: Chronic Kidney Disease, CTCAE


subject: MESH:D004164

subject_name: Diphosphonates


subject: MESH:D004164


subject: UMLS:C2267018

subject_name: Bisphosphonate [EPC]


subject: UMLS:C2267018


subject: UNII:3XVL385Q0M

subject_name: Filgotinib

object_name: Fistulising Crohn's disease


subject: UMLS:C5907966

subject_name: HIF-2alpha Inhibitor HS-10516

object_name: Advanced Clear Cell Renal Cell Carcinoma


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:27960

subject_name: Nitroarginine

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: Drug Interactions


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:90217

subject_name: Quizartinib


subject: PUBCHEM.COMPOUND:13620391

subject_name: ZOLPIDEM TARTRATE

object_name: Insomnia, CTCAE 3.0


subject: PUBCHEM.COMPOUND:13620391

object_name: Insomnia, CTCAE 5.0


subject: PUBCHEM.COMPOUND:13620391

object_name: Chronic Insomnia


subject: CHEBI:10125

subject_name: Zolpidem


subject: PUBCHEM.COMPOUND:57389748

subject_name: Linagliptin

object_name: Left Ventricular Systolic Dysfunction, CTCAE 3.0


subject: PUBCHEM.COMPOUND:57389748

object_name: Left Ventricular Systolic Dysfunction, CTCAE 5.0


subject: PUBCHEM.COMPOUND:57389748

object_name: Left ventricular systolic dysfunction


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: Acne inversa


subject: UMLS:C5783284

subject_name: ROPivacaine 0.75% injectable solution

object_name: lumbar spinal stenosis


subject: UMLS:C5783284

object_name: spinal stenosis


subject: UMLS:C5783284

object_name: Lumbar spine instability


subject: UMLS:C5783284

object_name: Lumbar spondylolisthesis


subject: UMLS:C5783284

object_name: lumbar disc herniation


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: cystic fibrosis


subject: UNII:8S5OIN36X4

subject_name: Seviteronel

object_name: castration-resistant prostate carcinoma


subject: UMLS:C3827068


subject: DRUGBANK:DB17668

object_name: methylmalonic acidemia


subject: UMLS:C5237265

subject_name: Alkotinib

object_name: non-small cell lung carcinoma


subject: CHEBI:165874

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C3248666

subject_name: Injection, belimumab, 10 mg administered

object_name: lupus nephritis


subject: UMLS:C3248666

object_name: Cancer Remission


subject: UMLS:C3248666

object_name: Remission


subject: UMLS:C3248666

object_name: Safety Issues


subject: UMLS:C5203380

subject_name: Belimumab Liquid Injection


subject: UMLS:C5203380


subject: UMLS:C5203380


subject: UMLS:C5203380


subject: UNII:73B0K5S26A

subject_name: Belimumab


subject: UNII:73B0K5S26A


subject: UNII:73B0K5S26A


subject: MESH:D007166

subject_name: Immunosuppressive Agents


subject: MESH:D007166


subject: MESH:D007166


subject: MESH:D007166


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)

object_name: Apathy


subject: CHEBI:131701

object_name: On examination - apathetic


subject: CHEBI:3360

subject_name: Cannabinol

object_name: Headache


subject: CHEBI:3360

object_name: Headache, CTCAE


subject: CHEBI:3360

object_name: Orofacial Pain


subject: CHEBI:3360

object_name: Tension-type headache


subject: CHEBI:3360

object_name: Muscular headache


subject: CHEBI:3360

object_name: Muscle Pain, CTCAE


subject: CHEBI:3360

object_name: Myalgia


subject: CHEBI:3360

object_name: Myalgia, CTCAE


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Wet age-related macular degeneration


subject: CHEBI:7565

subject_name: Nifedipine

object_name: Placenta Previa


subject: UMLS:C0036774

subject_name: serum albumin, bovine

object_name: clear cell renal carcinoma


subject: UMLS:C0036774

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C0036774

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C0036774

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C0036774

object_name: Clear-cell metastatic renal cell carcinoma


subject: UMLS:C0036774

object_name: Metastatic malignant neoplasm to bone


subject: UMLS:C0036774

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C0036774

object_name: Embolism, Tumor


subject: UMLS:C0036774

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422


subject: UNII:KC2JC2ZA04

subject_name: ZANZALINTINIB


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: chronic dacryocystitis


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: MESH:C000626207

subject_name: hydroxybutyl chitosan


subject: UNII:3M6325NY1R

subject_name: Iron isomaltoside 1000

object_name: nasopharyngeal carcinoma


subject: UNII:3M6325NY1R

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: GTOPDB:8458

subject_name: otelixizumab

object_name: euthyroid Graves orbitopathy


subject: GTOPDB:8458

object_name: endocrine exophthalmos


subject: UNII:I5HF2X04PB


subject: UNII:I5HF2X04PB


subject: UMLS:C2935224


subject: UMLS:C2935224


subject: UNII:2N71QUE3NL

object_name: pancreatic neoplasm


subject: UNII:2N71QUE3NL

object_name: exocrine pancreatic carcinoma


subject: UNII:2N71QUE3NL

object_name: malignant pancreatic neoplasm


subject: UNII:2N71QUE3NL

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:2N71QUE3NL

object_name: stage IV pancreatic cancer


subject: UNII:2N71QUE3NL

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C3640817

subject_name: Ipafricept


subject: UMLS:C3640817


subject: UMLS:C3640817


subject: UMLS:C3640817


subject: UMLS:C3640817


subject: UMLS:C3640817


subject: UNII:3ZY6J6Z6EE

subject_name: Droxidopa

object_name: 12-lead ECG QTc interval


subject: CHEBI:27375

subject_name: Vinblastine

object_name: Solid Neoplasm


subject: CHEBI:27375

object_name: central nervous system cancer


subject: CHEBI:9168

subject_name: Sirolimus


subject: PUBCHEM.COMPOUND:2516

subject_name: Cafestol

object_name: Abdominal obesity


subject: UMLS:C4745069

subject_name: Anti-PVRIG Monoclonal Antibody COM701

object_name: Advanced cancer


subject: UMLS:C4745069

object_name: triple-negative breast carcinoma


subject: UMLS:C4745069

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4745069

object_name: endometrial cancer


subject: UMLS:C4745069

object_name: uterine corpus cancer


subject: UMLS:C4745069

object_name: endometrial carcinoma


subject: UMLS:C4745069

object_name: colorectal carcinoma


subject: UMLS:C4745069

object_name: cancer


subject: UMLS:C4745069

object_name: Childhood Breast Carcinoma


subject: UMLS:C4745069

object_name: breast carcinoma


subject: UMLS:C4745069

object_name: breast cancer


subject: UMLS:C4745069

object_name: lung cancer


subject: UMLS:C4745069

object_name: lung neoplasm


subject: UMLS:C4745069

object_name: lung carcinoma


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: cardiovascular disorder


subject: CHEBI:7986

object_name: arteriosclerosis disorder


subject: CHEBI:7986

object_name: atherosclerosis


subject: UMLS:C3540798

subject_name: Food allergenic extracts

object_name: anemia


subject: CHEBI:5296

subject_name: Gemfibrozil


subject: CHEBI:58097

object_name: Drug action (disorder)


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:28240

subject_name: dichloroacetate

object_name: Neck Carcinoma


subject: CHEBI:28240

object_name: head and neck neoplasm


subject: CHEBI:28240

object_name: head and neck cancer


subject: CHEBI:36386

subject_name: Dichloroacetic acid


subject: CHEBI:36386


subject: CHEBI:36386


subject: UMLS:C0678171

subject_name: Pentasa

object_name: Crohn disease


subject: UMLS:C0042210

subject_name: Vaccines

object_name: nasopharyngeal carcinoma


subject: UMLS:C0042210

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C0042210

object_name: malignant tumor of nasopharynx


subject: UMLS:C0042210

object_name: EBV Infection


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5203254

subject_name: Rituximab Liquid Injection

object_name: IgA vasculitis


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: CHEBI:9144

subject_name: Silibinin

object_name: Overweight and obesity


subject: CHEBI:9144

object_name: inflammatory bowel disease


subject: CHEBI:9144

object_name: Insulin resistance


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:125451


subject: CHEBI:125451


subject: CHEBI:85993

subject_name: Palbociclib

object_name: endometrial cancer


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: interstitial cystitis


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:6824

subject_name: Methenamine


subject: UMLS:C1875126

subject_name: ESTROGENS,VAGINAL


subject: CHEBI:167309

subject_name: Methadone

object_name: no feeling or sensation of skin


subject: CHEBI:167309

object_name: Sensory Loss


subject: CHEBI:135673

subject_name: Rupatadine

object_name: Hepatic impairment


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:50731

object_name: pulmonary hypertension


subject: CHEBI:50731

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:50731

object_name: pulmonary arterial hypertension


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: chronic rhinosinusitis


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:60802

subject_name: ropivacaine

object_name: brain aneurysm


subject: CHEBI:29228

subject_name: FLUORIDE

object_name: periodontal disorder


subject: CHEBI:17051

subject_name: Fluoride ion


subject: UMLS:C3541971

subject_name: Fluoride supplements


subject: UMLS:C3714616

subject_name: Fluoride Drug Class


subject: CHEBI:164200

subject_name: Triclosan


subject: CHEBI:4672

subject_name: Docetaxel

object_name: malignant testicular germ cell tumor


subject: CHEBI:4672

object_name: neoplasm of testis


subject: CHEBI:4672

object_name: testicular cancer


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Angina pectoris


subject: CHEBI:231352

subject_name: Resminostat

object_name: mycosis fungoides


subject: CHEBI:231352

object_name: Sezary syndrome


subject: CHEBI:231352

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:231352

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Mantle cell lymphoma refractory


subject: CHEBI:52717

object_name: B-cell lymphoma refractory


subject: CHEBI:52717

object_name: B-cell lymphoma recurrent


subject: CHEBI:7459

subject_name: Naloxone

object_name: HIV infection


subject: CHEBI:5775

subject_name: Hydralazine

object_name: Metastatic Carcinoma to the Uterine Cervix


subject: UNII:Q400352CM2


subject: CHEBI:39867

subject_name: Valproic acid


subject: PUBCHEM.COMPOUND:129316491

object_name: CNS disorder


subject: PUBCHEM.COMPOUND:129316491

object_name: nervous system disorder


subject: PUBCHEM.COMPOUND:129316491

object_name: neuromuscular disease


subject: PUBCHEM.COMPOUND:129316491

object_name: motor neuron disorder


subject: PUBCHEM.COMPOUND:129316491

object_name: spinal cord disorder


subject: PUBCHEM.COMPOUND:129316491

object_name: TDP-43 proteinopathy


subject: UMLS:C5774003


subject: UMLS:C5774003


subject: UMLS:C5774003


subject: UMLS:C5774003


subject: UMLS:C5774003


subject: UMLS:C5774003


subject: CHEBI:46858

subject_name: L-tyrosine residue

object_name: Restless legs


subject: CHEBI:17895

subject_name: Tyrosine


subject: UMLS:C3489751

object_name: arteriosclerosis disorder


subject: UMLS:C3489751

object_name: atherosclerosis


subject: UMLS:C2940097

subject_name: Novaferrum Reformulated Oct 2010

object_name: anemia


subject: UMLS:C2940097

object_name: Anemia, CTCAE


subject: UMLS:C2940097

object_name: iron deficiency anemia


subject: CHEBI:131168

subject_name: Afuresertib

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:44567960

subject_name: VASOACTIVE INTESTINAL PEPTIDE

object_name: Sepsis


subject: PUBCHEM.COMPOUND:44567960

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:44567960

object_name: congenital alveolar dysplasia


subject: PUBCHEM.COMPOUND:44567960

object_name: respiratory distress syndrome in premature infants


subject: PUBCHEM.COMPOUND:44567960

object_name: adult acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:44567960

object_name: newborn respiratory distress syndrome


subject: CHEBI:80331

subject_name: Vasoactive intestinal peptide


subject: CHEBI:80331


subject: CHEBI:80331


subject: CHEBI:80331


subject: CHEBI:80331


subject: CHEBI:80331


subject: UMLS:C0042395

subject_name: vasoactive intestinal peptide


subject: UMLS:C0042395


subject: UMLS:C0042395


subject: UMLS:C0042395


subject: UMLS:C0042395


subject: UMLS:C0042395


subject: PUBCHEM.COMPOUND:70691420

subject_name: Aviptadil


subject: PUBCHEM.COMPOUND:70691420


subject: PUBCHEM.COMPOUND:70691420


subject: PUBCHEM.COMPOUND:70691420


subject: PUBCHEM.COMPOUND:70691420


subject: PUBCHEM.COMPOUND:70691420


subject: CHEBI:174615

object_name: primary central nervous system lymphoma


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:41264

subject_name: butyl group


subject: CHEBI:4911

subject_name: Etoposide


subject: UMLS:C0733688


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]

object_name: Heparin overdose of undetermined intent


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:4305

subject_name: dacarbazine

object_name: Childhood Leiomyosarcoma


subject: CHEBI:4305

object_name: Adult Leiomyosarcoma


subject: CHEBI:6801

subject_name: Metformin

object_name: brain neoplasm


subject: UNII:PTK42Z5STX

object_name: ulcerative colitis


subject: UNII:PTK42Z5STX

object_name: inflammatory bowel disease 1


subject: MESH:C000728461

object_name: renal carcinoma


subject: MESH:C000728461

object_name: kidney cancer


subject: MESH:C000728461

object_name: prostate carcinoma


subject: MESH:C000728461

object_name: prostate cancer


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: uveitis


subject: UNII:2S9ZZM9Q9V

object_name: Uveitis, CTCAE


subject: UMLS:C1739076

object_name: head and neck squamous cell carcinoma


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Well adult


subject: CHEBI:35687


subject: CHEBI:35686


subject: CHEBI:45475


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: interstitial lung disease 1


subject: CHEBI:4026

object_name: interstitial lung disease 2


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: UMLS:C4053672

object_name: metastatic colorectal cancer


subject: UNII:SI8K6KX6FA

object_name: systemic sclerosis


subject: MESH:D056692

subject_name: Prebiotics

object_name: schizophrenia


subject: MESH:D056692

object_name: schizoaffective disorder


subject: MESH:D056692

object_name: schizophrenia 18


subject: CHEMBL.COMPOUND:CHEMBL2109330

object_name: adult acute respiratory distress syndrome


subject: CHEMBL.COMPOUND:CHEMBL2109330

object_name: lung disorder


subject: UMLS:C5417932

subject_name: IC 14


subject: UMLS:C5417932


subject: UMLS:C3853755

subject_name: testosterone 1% Topical Gel, includes 60 ACTUAT Pump, 2500 MG Packet and 5000 MG Packet

object_name: sarcopenia


subject: UMLS:C3853755

object_name: myopathy


subject: UMLS:C3853755

object_name: muscle tissue disorder


subject: UMLS:C3853755

object_name: hypogonadism


subject: CHEBI:187893

subject_name: Baclofen

object_name: substance abuse


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:94614

subject_name: Opipramol


subject: CHEBI:62880

subject_name: Veliparib

object_name: BRCA2 gene mutation


subject: CHEBI:62880

object_name: BRCA1 gene mutation


subject: UMLS:C1831920

subject_name: ABT 888

object_name: Carcinoma breast stage IV


subject: UMLS:C1831920


subject: UMLS:C1831920


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: UMLS:C1577018

subject_name: cyclosporine microemulsion

object_name: dry eye syndrome


subject: MESH:D000941

subject_name: Antigens

object_name: influenza


subject: CHEBI:40618

subject_name: Pimagedine

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0002521

subject_name: Amino Acids, Branched-Chain

object_name: Frailty Syndrome


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: Sedation


subject: PUBCHEM.COMPOUND:135512673

object_name: Sedated


subject: PUBCHEM.COMPOUND:135512673

object_name: no feeling or sensation of skin


subject: PUBCHEM.COMPOUND:135512673

object_name: Sensory Loss


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: CHEBI:90237

subject_name: Tandutinib

object_name: glioblastoma


subject: CHEBI:90237

object_name: Brain Stem Glioblastoma


subject: CHEBI:90237

object_name: glioma susceptibility 1


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: alcoholic hepatitis


subject: UNII:513P80B4YJ

subject_name: Avapritinib

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:513P80B4YJ

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UNII:513P80B4YJ

object_name: Locally Advanced Sarcoma


subject: UNII:513P80B4YJ

object_name: Locally Advanced Melanoma


subject: UNII:513P80B4YJ

object_name: metastatic melanoma


subject: UNII:513P80B4YJ

object_name: Metastatic sarcoma


subject: UNII:513P80B4YJ

object_name: Locally Advanced Primary Malignant Central Nervous System Neoplasm


subject: UNII:513P80B4YJ

object_name: Metastatic Primary Malignant Central Nervous System Neoplasm


subject: UNII:513P80B4YJ

object_name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:513P80B4YJ

object_name: Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:513P80B4YJ

object_name: Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:513P80B4YJ

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:513P80B4YJ

object_name: Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:513P80B4YJ

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:513P80B4YJ

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:513P80B4YJ

object_name: Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:513P80B4YJ

object_name: Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:513P80B4YJ

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:513P80B4YJ

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:513P80B4YJ

object_name: Stage IIIC Colorectal Cancer AJCC v8


subject: UNII:513P80B4YJ

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:513P80B4YJ

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: UNII:513P80B4YJ

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: UNII:513P80B4YJ

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: UNII:513P80B4YJ

object_name: Stage IV Colorectal Cancer AJCC v8


subject: UNII:513P80B4YJ

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UNII:513P80B4YJ

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:513P80B4YJ

object_name: Stage IVA Lung Cancer AJCC v8


subject: UNII:513P80B4YJ

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:24433

subject_name: group

object_name: Coronavinae infectious disease


subject: UNII:A2VM2V569A

object_name: medulloblastoma


subject: UNII:A2VM2V569A

object_name: childhood medulloblastoma


subject: UNII:A2VM2V569A

object_name: adult medulloblastoma


subject: UNII:A2VM2V569A

object_name: Childhood Neuroblastoma


subject: UNII:A2VM2V569A

object_name: neuroblastoma


subject: UNII:A2VM2V569A

object_name: Recurrent disease


subject: UNII:A2VM2V569A

object_name: Global Relapse in Viscera


subject: UNII:A2VM2V569A

object_name: Global Relapse in Lymph Nodes


subject: UNII:A2VM2V569A

object_name: Relapse Following Intervention for Kawasaki Disease


subject: UNII:A2VM2V569A

object_name: Global Relapse


subject: UNII:A2VM2V569A

object_name: Global Relapse in Skin


subject: UNII:A2VM2V569A

object_name: Global Relapse in Blood


subject: UNII:Z5MR2Y1IJJ

subject_name: Enavogliflozin

object_name: type 2 diabetes mellitus


subject: CHEBI:91432

subject_name: Brivanib

object_name: digestive system cancer


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: melanoma


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:95165

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:95165

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:95165

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: GTOPDB:4934

object_name: myeloid neoplasm


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Melanoma, Experimental


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin


subject: PR:000001379


subject: CHEBI:5181

subject_name: fucoidan

object_name: rheumatoid arthritis


subject: CHEBI:6706

subject_name: Mecamylamine

object_name: macular degeneration


subject: CHEBI:6706

object_name: retinitis pigmentosa 30


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Primary malignant neoplasm


subject: CHEBI:39548

object_name: childhood malignant neoplasm


subject: CHEBI:39548

object_name: Malignant obstetric neoplasm


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: pulmonary fibrosis


subject: UNII:2S9ZZM9Q9V

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:35341

subject_name: steroid

object_name: voice disorders


subject: CHEBI:35341

object_name: Dysphonia


subject: CHEBI:35341

object_name: Hoarse voice


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: prostate carcinoma


subject: CHEBI:15698

object_name: prostate cancer


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: alcohol abuse


subject: UNII:N5UK68MGDZ

object_name: alcohol dependence


subject: CHEBI:86285

object_name: acute kidney failure


subject: CHEBI:86285

object_name: Acute Kidney Injury, CTCAE


subject: PUBCHEM.COMPOUND:53394576


subject: PUBCHEM.COMPOUND:53394576


subject: CHEBI:49040

subject_name: Ezetimibe


subject: CHEBI:49040


subject: CHEBI:63660


subject: CHEBI:63660


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: CHEBI:132112

object_name: deafness


subject: CHEBI:132112

object_name: hearing loss by exam


subject: CHEBI:132112

object_name: Stage III Testicular Cancer AJCC v8


subject: CHEBI:132112

object_name: Stage II Testicular Cancer AJCC v8


subject: CHEBI:132112

object_name: Metastatic Malignant Germ Cell Tumor


subject: CHEBI:132112

object_name: Metastatic Malignant Nongerminomatous Germ Cell Tumor


subject: UMLS:C0534500

object_name: gastroparesis


subject: UMLS:C0534500

object_name: Gastroparesis, CTCAE


subject: CHEBI:229573

object_name: metabolic disease


subject: CHEBI:8633

subject_name: Puerarin


subject: CHEBI:125427

object_name: type 1 diabetes mellitus


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: peritoneum cancer


subject: CHEBI:135920

subject_name: Fesoterodine

object_name: Neurogenic detrusor overactivity


subject: CHEBI:10033

subject_name: Warfarin

object_name: aortic valve disorder


subject: CHEBI:10033

object_name: aortic valve disease 1


subject: CHEBI:10033

object_name: Aortic Valve Disease, CTCAE


subject: CHEBI:10033

object_name: aortic valve insufficiency


subject: CHEBI:10033

object_name: aortic valve disease 2


subject: CHEBI:10033

object_name: aortic stenosis


subject: CHEBI:10033

object_name: aortic valve disease 3


subject: CHEBI:10033

object_name: Stenosis of aorta


subject: CHEBI:86158

subject_name: calcium chloride dihydrate

object_name: Out-of-Hospital Cardiac Arrest


subject: CHEBI:3312

subject_name: Calol


subject: CHEBI:71015

subject_name: perampanel hydrate

object_name: epilepsy


subject: PUBCHEM.COMPOUND:123812

subject_name: heliox

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: PUBCHEM.COMPOUND:123812

object_name: acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:123812

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: PUBCHEM.COMPOUND:123812

object_name: adult acute respiratory distress syndrome


subject: UNII:OP35X9610Y

object_name: Adult growth hormone deficiency


subject: CHEBI:3441

subject_name: Carvedilol

object_name: acute myocardial infarction


subject: CHEBI:3441

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: anxiety disorder


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: carcinoid tumor


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C2746073

subject_name: Somatostatin Receptor Agonist


subject: UMLS:C0732165

subject_name: Somatostatin analog


subject: UMLS:C3536825

subject_name: Somatostatin Analog [EPC]


subject: CHEBI:32599

object_name: pregnancy preterm


subject: CHEBI:7565

subject_name: Nifedipine


subject: DRUGBANK:DB15803

subject_name: Dendritic cells vaccine

object_name: brain neoplasm


subject: DRUGBANK:DB15803

object_name: brain cancer


subject: DRUGBANK:DB15803

object_name: Brain Stem Glioblastoma


subject: DRUGBANK:DB15803

object_name: glioma susceptibility 1


subject: DRUGBANK:DB15803

object_name: High grade glioma


subject: DRUGBANK:DB15803

object_name: glioma


subject: CHEBI:46053

subject_name: Trinitrotoluene

object_name: rectal carcinoma


subject: CHEBI:46053

object_name: rectal cancer


subject: CHEBI:46053

object_name: Childhood Rectal Carcinoma


subject: CHEBI:46053

object_name: Locally Advanced Rectal Adenocarcinoma


subject: CHEBI:46053

object_name: rectum adenocarcinoma


subject: CHEBI:27808

subject_name: Diamorphine


subject: CHEBI:27808


subject: CHEBI:27808


subject: CHEBI:27808


subject: CHEBI:27808


subject: PR:000016508

subject_name: troponin T, slow skeletal muscle


subject: PR:000016508


subject: PR:000016508


subject: PR:000016508


subject: PR:000016508


subject: UMLS:C0077404

subject_name: Troponin T


subject: UMLS:C0077404


subject: UMLS:C0077404


subject: UMLS:C0077404


subject: UMLS:C0077404


subject: CHEBI:8863

subject_name: Riluzole

object_name: Huntington disease


subject: UNII:D959AE5USF

subject_name: clofazimine

object_name: HIV infection


subject: UMLS:C0885467

subject_name: Juglans regia preparation

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C0885467

object_name: metabolic syndrome X


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: diffuse large B-cell lymphoma of the central nervous system


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: PUBCHEM.COMPOUND:23667621

subject_name: DEXAMETHASONE SODIUM PHOSPHATE

object_name: Macular Edema


subject: PUBCHEM.COMPOUND:23667621

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:23667621

object_name: Diabetes


subject: PUBCHEM.COMPOUND:23667621

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:23667621

object_name: Pseudophakia


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:31607

subject_name: Ferrous fumarate

object_name: colorectal carcinoma


subject: CHEBI:31607

object_name: Surgical procedure finding


subject: CHEBI:29034

subject_name: Ferric cation


subject: CHEBI:29034


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin

object_name: Intraoperative Hemorrhage


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: CHEBI:8060

subject_name: Phenelzine

object_name: Prostate cancer recurrent


subject: CHEBI:8060

object_name: Stage I Prostate Cancer AJCC v6


subject: CHEBI:8060

object_name: Prostate cancer stage I


subject: CHEBI:8060

object_name: Stage I Prostate Cancer AJCC v8


subject: CHEBI:8060

object_name: Stage I Prostate Cancer AJCC v7


subject: CHEBI:8060

object_name: Stage IIA Prostate Cancer AJCC v7


subject: CHEBI:8060

object_name: Stage IIA Prostate Cancer AJCC v8


subject: CHEBI:8060

object_name: Stage IIB Prostate Cancer AJCC v8


subject: CHEBI:8060

object_name: Stage IIB Prostate Cancer AJCC v7


subject: CHEBI:8060

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:8060

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:8060

object_name: Carcinoma of the prostate stage III


subject: CHEBI:8060

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:8060

object_name: prostate adenocarcinoma


subject: CHEBI:47781

subject_name: Desipramine

object_name: small cell lung carcinoma


subject: CHEBI:47781

object_name: neuroendocrine neoplasm


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered

object_name: brain cancer


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: Incontinence


subject: PUBCHEM.COMPOUND:18319735

object_name: Urinary Incontinence, CTCAE 3.0


subject: UMLS:C3710140

subject_name: Tolterodine Tartrate ER


subject: UMLS:C3710140

object_name: Urinary incontinence


subject: UMLS:C3710140

object_name: Urinary Incontinence, CTCAE 5.0


subject: UMLS:C3710140

object_name: urgency urinary incontinence


subject: UMLS:C3710140


subject: UMLS:C3710140

object_name: Urinary Urgency


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: bladder tumor


subject: CHEBI:90001

object_name: urinary bladder carcinoma


subject: CHEBI:90001

object_name: urinary bladder cancer


subject: CHEBI:90001

object_name: childhood bladder carcinoma


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: CHEBI:26536

subject_name: retinoic acid

object_name: Wilms tumor 1


subject: CHEBI:26536

object_name: nephroblastoma


subject: CHEBI:26536

object_name: Wilms tumor


subject: CHEBI:28870


subject: CHEBI:28870


subject: CHEBI:28870


subject: CHEBI:15367

subject_name: Tretinoin


subject: CHEBI:15367


subject: CHEBI:15367


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:6067

subject_name: Isotretinoin


subject: CHEBI:8405

subject_name: Primaquine

object_name: Plasmodium falciparum infection


subject: UMLS:C3852764

subject_name: PEG-rhG-CSF

object_name: Severe Aplastic Anemia


subject: UMLS:C3852764

object_name: severe aplastic anemia


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: CINCA syndrome


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: Myocardial Infarction, CTCAE


subject: MESH:D000077203

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]

object_name: myocardial infarction


subject: UMLS:C3542461


subject: UMLS:C3542461


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: hereditary hemorrhagic telangiectasia


subject: UMLS:C0677666

subject_name: soy protein isolate


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: HPV positive oropharyngeal squamous cell carcinoma


subject: UNII:28X28X9OKV

object_name: HPV-related carcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: MESH:C000657484

object_name: oropharyngeal carcinoma


subject: MESH:C000657484

object_name: oropharynx cancer


subject: MESH:C000657484


subject: MESH:C000657484


subject: UMLS:C3714648

subject_name: Vitamin K Drug Class

object_name: metabolic bone disorder


subject: UMLS:C3714648

object_name: disorder of aging


subject: UMLS:C3541380

subject_name: Vitamin K containing hemostatics


subject: UMLS:C3541380


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:28384


subject: CHEBI:18067

subject_name: Phylloquinone


subject: CHEBI:18067


subject: UMLS:C2936884

subject_name: Vitamin K [EPC]


subject: UMLS:C2936884


subject: CHEBI:44245

subject_name: Menaquinone 7

object_name: osteoporosis


subject: CHEBI:44245

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:44245

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:44245

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:44245


subject: CHEBI:44245


subject: UMLS:C0338133

subject_name: Gemzar

object_name: Advanced Pancreatic Adenocarcinoma


subject: UMLS:C0338133

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C2701862

subject_name: CarBAMazepine ER

object_name: bipolar disorder


subject: UMLS:C2701862

object_name: bipolar depression


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: transitional cell carcinoma


subject: UNII:15C2VL427D

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: UNII:15C2VL427D

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: UNII:15C2VL427D

object_name: bladder adenocarcinoma


subject: UNII:15C2VL427D

object_name: bladder squamous cell carcinoma


subject: UNII:15C2VL427D

object_name: Recurrent Urethral Cancer


subject: UNII:15C2VL427D

object_name: Bladder cancer recurrent


subject: UNII:15C2VL427D

object_name: Distal Urethral Carcinoma


subject: UNII:15C2VL427D

object_name: Stage III Urethral Cancer AJCC v8


subject: UNII:15C2VL427D

object_name: Stage III Urethral Cancer AJCC v7


subject: UNII:15C2VL427D

object_name: posterior urethra cancer


subject: UNII:15C2VL427D

object_name: Proximal Urethral Carcinoma


subject: UNII:15C2VL427D

object_name: urethral carcinoma associated with invasive bladder cancer


subject: UNII:15C2VL427D

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: UNII:15C2VL427D

object_name: Stage III Bladder Cancer AJCC v8


subject: UNII:15C2VL427D

object_name: Stage IV Bladder Cancer AJCC v8


subject: UNII:15C2VL427D

object_name: Stage IV Bladder Cancer AJCC v7


subject: UNII:15C2VL427D

object_name: Bladder cancer stage IV


subject: UNII:15C2VL427D

object_name: Stage IV Bladder Cancer AJCC v6


subject: UMLS:C0178601

subject_name: Dopamine Agonists

object_name: Disinhibition


subject: CHEBI:15765

subject_name: Levodopa


subject: CHEBI:3395

subject_name: carbidopa


subject: CHEBI:94430

subject_name: DL-Carbidopa


subject: CHEBI:39585

subject_name: Carbidopa


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Shwachman-Diamond syndrome


subject: UNII:PVI5M0M1GW

object_name: dyskeratosis congenita


subject: UNII:PVI5M0M1GW

object_name: thrombocytopenia


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: non-small cell lung carcinoma


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: CHEBI:6121

subject_name: Ketamine

object_name: subarachnoid hemorrhage


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: paraganglioma


subject: CHEBI:72317

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: CHEBI:72317

object_name: adrenal gland pheochromocytoma


subject: CHEBI:72317

object_name: pheochromocytoma


subject: CHEBI:72317

object_name: esophageal adenocarcinoma


subject: CHEBI:72317

object_name: lung adenocarcinoma


subject: CHEBI:72317

object_name: cervical adenocarcinoma


subject: CHEBI:72317

object_name: adenocarcinoma


subject: CHEBI:72317

object_name: bile duct adenocarcinoma


subject: CHEBI:91414

subject_name: Adavosertib

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:91414

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:83766

subject_name: Olaparib

object_name: Refractory Malignant Solid Neoplasm


subject: UMLS:C0013162

subject_name: Drug Combinations

object_name: hypertension


subject: UMLS:C0013162

object_name: Hypertension, CTCAE


subject: UMLS:C0013162

object_name: hyperlipidemia


subject: GTOPDB:2479

subject_name: HCl

object_name: type 2 diabetes mellitus


subject: UMLS:C1512523

subject_name: hydrochloride


subject: UMLS:C0443985

subject_name: Flinders medical centre-7 marker


subject: CHEBI:17883

subject_name: Hydrochloric acid


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:70839

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:70839

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:70839

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:70839

object_name: salivary gland squamous cell carcinoma


subject: CHEBI:70839

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:70839

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:70839

object_name: stage IVB squamous cell carcinoma of the larynx


subject: CHEBI:70839

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:70839

object_name: stage IVA squamous cell carcinoma of the larynx


subject: CHEBI:70839

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:70839

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:70839

object_name: stage IVC squamous cell carcinoma of the larynx


subject: CHEBI:70839

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:70839

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:70839

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:70839

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:70839

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:70839

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:70839

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:70839

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:70839

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:70839

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:70839

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:70839

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:70839

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:70839

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:70839

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:70839

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:70839

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:70839

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:70839

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:70839

object_name: tongue cancer


subject: CHEBI:70839

object_name: tongue carcinoma


subject: CHEBI:70839

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:70839

object_name: stage IVA verrucous carcinoma of the larynx


subject: CHEBI:70839

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:70839

object_name: stage IVB verrucous carcinoma of the larynx


subject: CHEBI:70839

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:70839

object_name: stage IVC verrucous carcinoma of the larynx


subject: CHEBI:70839

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:70839

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:70839

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: CHEBI:70839

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:70839

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:70839

object_name: stage IVB salivary gland cancer


subject: CHEBI:70839

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:70839

object_name: stage IVA salivary gland cancer


subject: CHEBI:70839

object_name: stage IVC salivary gland cancer


subject: CHEBI:70839

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:190514

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:190514

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:190514

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:190514

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:190514

object_name: salivary gland squamous cell carcinoma


subject: CHEBI:190514

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:190514

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:190514

object_name: stage IVB squamous cell carcinoma of the larynx


subject: CHEBI:190514

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:190514

object_name: stage IVA squamous cell carcinoma of the larynx


subject: CHEBI:190514

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:190514

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:190514

object_name: stage IVC squamous cell carcinoma of the larynx


subject: CHEBI:190514

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:190514

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:190514

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:190514

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:190514

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:190514

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:190514

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:190514

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:190514

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:190514

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:190514

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:190514

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:190514

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:190514

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:190514

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:190514

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:190514

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:190514

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:190514

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:190514

object_name: tongue cancer


subject: CHEBI:190514

object_name: tongue carcinoma


subject: CHEBI:190514

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:190514

object_name: stage IVA verrucous carcinoma of the larynx


subject: CHEBI:190514

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:190514

object_name: stage IVB verrucous carcinoma of the larynx


subject: CHEBI:190514

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:190514

object_name: stage IVC verrucous carcinoma of the larynx


subject: CHEBI:190514

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:190514

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:190514

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: CHEBI:190514

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:190514

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:190514

object_name: stage IVB salivary gland cancer


subject: CHEBI:190514

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:190514

object_name: stage IVA salivary gland cancer


subject: CHEBI:190514

object_name: stage IVC salivary gland cancer


subject: CHEBI:190514

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:49375

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:49375

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:49375

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:49375

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:49375

object_name: salivary gland squamous cell carcinoma


subject: CHEBI:49375

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:49375

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:49375

object_name: stage IVB squamous cell carcinoma of the larynx


subject: CHEBI:49375

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49375

object_name: stage IVA squamous cell carcinoma of the larynx


subject: CHEBI:49375

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49375

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49375

object_name: stage IVC squamous cell carcinoma of the larynx


subject: CHEBI:49375

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:49375

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49375

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:49375

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:49375

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49375

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:49375

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49375

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:49375

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:49375

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:49375

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:49375

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:49375

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:49375

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:49375

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:49375

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:49375

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:49375

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:49375

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:49375

object_name: tongue cancer


subject: CHEBI:49375

object_name: tongue carcinoma


subject: CHEBI:49375

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:49375

object_name: stage IVA verrucous carcinoma of the larynx


subject: CHEBI:49375

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:49375

object_name: stage IVB verrucous carcinoma of the larynx


subject: CHEBI:49375

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:49375

object_name: stage IVC verrucous carcinoma of the larynx


subject: CHEBI:49375

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:49375

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:49375

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: CHEBI:49375

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:49375

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:49375

object_name: stage IVB salivary gland cancer


subject: CHEBI:49375

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:49375

object_name: stage IVA salivary gland cancer


subject: CHEBI:49375

object_name: stage IVC salivary gland cancer


subject: CHEBI:49375

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Abnormal left ventricular function


subject: CHEBI:85078

object_name: anterolateral myocardial infarction


subject: CHEBI:85078

object_name: Non-ST Elevated Myocardial Infarction


subject: CHEBI:85078

object_name: Non-ST Elevation Myocardial Infarction


subject: UMLS:C3833608

subject_name: Glycosade

object_name: glycogen storage disorder due to hepatic glycogen synthase deficiency


subject: UMLS:C3833608

object_name: glycogen storage disease Ib


subject: UMLS:C3833608

object_name: glycogen storage disease I


subject: UMLS:C3833608

object_name: glycogen storage disease due to glucose-6-phosphatase deficiency type IA


subject: UMLS:C3833608

object_name: glycogen storage disease III


subject: UMLS:C1509017

subject_name: INJECTION, VERTEPORFIN, 0.1 MG ADMINISTERED

object_name: Scar formation


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:135423438

object_name: prostate neoplasm


subject: UMLS:C1879771

subject_name: BIBF 1120


subject: UMLS:C1879771


subject: CHEBI:85164


subject: CHEBI:85164


subject: UMLS:C5235872

subject_name: CDK1 Inhibitor BEY1107

object_name: glioblastoma


subject: UMLS:C5235872

object_name: Brain Stem Glioblastoma


subject: UMLS:C5235872

object_name: glioma susceptibility 1


subject: UNII:IN59K53GI9

subject_name: Vilaprisan

object_name: endometriosis


subject: UMLS:C4508945


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b

object_name: candidemia


subject: UMLS:C0021741

subject_name: Actimmune


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: psoriasis


subject: CHEBI:174615

object_name: nodular ganglioneuroblastoma


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:31355

subject_name: Carboplatin


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:50223

subject_name: Dexrazoxane

object_name: Childhood Neuroblastoma


subject: CHEBI:50223

object_name: neuroblastoma


subject: CHEBI:50223

object_name: Childhood Ganglioneuroblastoma


subject: CHEBI:50223

object_name: ganglioneuroblastoma


subject: CHEBI:50223


subject: UNII:7SQY4ZUD30

subject_name: Dinutuximab


subject: UNII:7SQY4ZUD30


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: CHEBI:4911

subject_name: Etoposide


subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib


subject: PUBCHEM.COMPOUND:78162481


subject: PUBCHEM.COMPOUND:78162481


subject: CHEBI:28876

subject_name: Melphalan


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:63632

subject_name: Topotecan


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:38940

subject_name: Sunitinib

object_name: brain neoplasm


subject: CHEBI:681848

subject_name: Doxapram

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:681848

object_name: COPD, severe early onset


subject: CHEBI:681848

object_name: chronic obstructive pulmonary disease


subject: CHEBI:681848

object_name: Mechanical ventilation finding


subject: CHEMBL.COMPOUND:CHEMBL1089636

object_name: Childhood Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1089636

object_name: breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1089636

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL1089636

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C2604057


subject: UMLS:C2604057


subject: UMLS:C2604057


subject: UMLS:C2604057


subject: CHEBI:183803

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:131801658


subject: CHEBI:94366

subject_name: itraconazole

object_name: graft versus host disease


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Rest limb pain


subject: CHEBI:50513

subject_name: mydriatic agent

object_name: type 2 diabetes mellitus


subject: CHEBI:50513

object_name: Diabetes


subject: CHEBI:50513

object_name: diabetes mellitus


subject: UMLS:C0026964

subject_name: Mydriatics


subject: UMLS:C0026964


subject: UMLS:C0026964


subject: PUBCHEM.COMPOUND:71300864

object_name: Hypertension, severe


subject: UMLS:C2933615

subject_name: LCZ 696


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: brain aneurysm


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: DRUGBANK:DB17575

subject_name: Utidelone

object_name: carcinoma of esophagus


subject: DRUGBANK:DB17575

object_name: esophageal cancer


subject: DRUGBANK:DB17575

object_name: Childhood Esophageal Carcinoma


subject: DRUGBANK:DB17575

object_name: neoplasm of esophagus


subject: CHEBI:2469

subject_name: Adefovir

object_name: viral disease


subject: UNII:ZAM5J1ATF2

subject_name: CIBISATAMAB

object_name: colorectal cancer


subject: UNII:ZAM5J1ATF2

object_name: colorectal carcinoma


subject: UNII:ZAM5J1ATF2

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3896776

subject_name: cibisatamab


subject: UMLS:C3896776


subject: UMLS:C3896776


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UMLS:C4733686

object_name: ovarian cancer


subject: UMLS:C4733686

object_name: ovarian neoplasm


subject: UMLS:C4733686

object_name: ovarian carcinoma


subject: CHEBI:75270

subject_name: Nimustine

object_name: glioblastoma


subject: CHEBI:75270

object_name: Childhood Glioblastoma


subject: CHEBI:75270

object_name: adult glioblastoma


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: hereditary hyperbilirubinemia


subject: CHEBI:16347

object_name: hyperbilirubinemia


subject: CHEMBL.COMPOUND:CHEMBL2108015

subject_name: VITAMIN B COMPLEX

object_name: acute lymphoblastic leukemia


subject: CHEMBL.COMPOUND:CHEMBL2108015


subject: CHEMBL.COMPOUND:CHEMBL2108015


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:27470


subject: UMLS:C5667109

subject_name: PARP/TNK Inhibitor JPI-547


subject: UMLS:C5667109


subject: UMLS:C5667109


subject: PUBCHEM.COMPOUND:3379942

subject_name: cefuroxime axetil

object_name: urinary system disorder


subject: CHEBI:3515

subject_name: Cefuroxime


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:36704

subject_name: Imiquimod

object_name: cutaneous leishmaniasis


subject: CHEMBL.COMPOUND:CHEMBL4650421

subject_name: RECOMBINANT HUMAN INTERLEUKIN-15

object_name: head and neck squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Metastatic non-small cell lung cancer


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Non-small cell lung cancer stage IIIA


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Non-small cell lung cancer stage IIIB


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Stage IV Renal Cell Cancer


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Non-small cell lung cancer recurrent


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Stage III renal cell cancer


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Recurrent Head and Neck Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Renal cell carcinoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Recurrent Skin Carcinoma


subject: UMLS:C1522569

subject_name: Interleukin-15, human recombinant

object_name: head and neck squamous cell carcinoma


subject: UMLS:C1522569

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C1522569

object_name: Non-small cell lung cancer stage IIIA


subject: UMLS:C1522569

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C1522569

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C1522569

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C1522569

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C1522569

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C1522569

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C1522569

object_name: Stage III renal cell cancer


subject: UMLS:C1522569

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C1522569

object_name: Recurrent Head and Neck Carcinoma


subject: UMLS:C1522569

object_name: Renal cell carcinoma recurrent


subject: UMLS:C1522569

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: UMLS:C1522569

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: UMLS:C1522569

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: UMLS:C1522569

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C1522569

object_name: Recurrent Skin Carcinoma


subject: CHEBI:90227

subject_name: Selumetinib

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:90227

object_name: Recurrent Rectal Cancer


subject: CHEBI:90227

object_name: Colon cancer recurrent


subject: CHEBI:90227

object_name: stage IVA rectal cancer


subject: CHEBI:90227

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:90227

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:90227

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:90227

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:90227

object_name: stage IVB rectal cancer


subject: CHEBI:90227

object_name: stage IVB colon cancer


subject: CHEBI:90227

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:90227

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:90227

object_name: stage IVA colon cancer


subject: CHEBI:90227

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:90227

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: metastatic prostate carcinoma


subject: CHEBI:233314

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:233314

object_name: Recurrent Glioblastoma


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Bedwetting


subject: CHEBI:16796

subject_name: Melatonin


subject: MESH:C000633847

object_name: diabetic macular edema


subject: MESH:C000633847

object_name: diabetes mellitus


subject: UNII:MWC0ET1L2P

subject_name: Monophosphoryl lipid A

object_name: herpes simplex


subject: PR:000022848

subject_name: guanosine-inosine kinase


subject: UniProtKB:P0AEW6

subject_name: INGK_ECOLI Guanosine-inosine kinase (sprot)


subject: PUBCHEM.COMPOUND:145946918

subject_name: SPINOSAD

object_name: Pediculosis


subject: CHEBI:36704

object_name: avian influenza


subject: PUBCHEM.COMPOUND:11422859

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:11422859

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: fetal growth restriction


subject: CHEBI:192614

object_name: Fetal growth abnormality


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Airway complication of anaesthesia


subject: UMLS:C0795657

subject_name: Aralast

object_name: Acute on chronic graft-versus-host disease


subject: UMLS:C0002191

subject_name: alpha 1-antitrypsin


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: colorectal neoplasm


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: PUBCHEM.COMPOUND:84036

subject_name: Aldoxorubicin

object_name: Locally Advanced Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:84036

object_name: Unresectable Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:84036

object_name: Metastatic Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:84036

object_name: Metastatic Soft Tissue Sarcoma


subject: UMLS:C2348337


subject: UMLS:C2348337


subject: UMLS:C2348337


subject: UMLS:C2348337


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: Acute respiratory infections


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:4910

subject_name: Etomidate

object_name: delirium


subject: CHEBI:4910

object_name: Delirium, CTCAE


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Blood Pressure Finding


subject: CHEBI:25681

object_name: Systemic arterial pressure


subject: CHEBI:32090

subject_name: Rebamipide

object_name: rheumatoid arthritis


subject: CHEBI:228302

subject_name: Zuranolone

object_name: Maternity blues


subject: CHEBI:63577

subject_name: Lamivudine

object_name: Chronic infection


subject: CHEBI:63577

object_name: Viremia


subject: CHEBI:63577

object_name: Viremia, CTCAE


subject: CHEBI:63624

subject_name: Telbivudine


subject: CHEBI:63624


subject: CHEBI:63624


subject: CHEBI:4466

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: UNII:7N8K34P2XH


subject: CHEBI:44915

subject_name: Propofol

object_name: non-small cell lung carcinoma


subject: UNII:GBW044919E

subject_name: FOSBRETABULIN TROMETHAMINE

object_name: neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:100154


subject: UMLS:C1541326

object_name: Alzheimer disease


subject: CHEBI:49017

subject_name: methional

object_name: photosensitivity disease


subject: CHEBI:340824

subject_name: methylphosphate


subject: CHEBI:59761

subject_name: methyl phosphate(2-)


subject: UMLS:C0623362

subject_name: Matrix Metalloproteinases


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil